Douglas C. Ross is a partner in the Seattle office of Davis Wright Tremaine, where he concentrates...
Jeffrey W. Brennan is a partner at McDermott Will & Emery and has practiced exclusively in antitrust...
Hilla Shimshoni is an associate in Alston & Bird’s Litigation & Trial Practice Group, focusing on antitrust....
Published: | June 5, 2018 |
Podcast: | On the Road |
What new developments has health care antitrust law undergone in recent years and what has caused it to change? In this report from the ABA Section of Antitrust Law Spring Meeting 2018, host Hilla Shimshoni discusses with Doug Ross and Jeff Brennan their opinions about what’s going on with health care antitrust, whether the Trump Administration has changed any enforcement trends and what the Federal Trade Commission is doing today. They also cover current topics, such as the California v. Sutter Health System case and the AT&T Time Warner merger.
Douglas C. Ross is a partner in the Seattle office of Davis Wright Tremaine, where he concentrates his practice in antitrust and litigation, and an adjunct faculty member at the University of Washington Law School, where he teaches the antitrust course and a seminar on competition in health care.
Jeffrey W. Brennan (Jeff) is a partner at McDermott Will & Emery and has practiced exclusively antitrust law for three decades, including more than 20 years in private practice and nearly 10 years over two tours at the Federal Trade Commission, from 1985 to 1990 as a staff attorney handling mergers and from 2001 to 2006 as assistant director, then associate director, of the Bureau of Competition.
Notify me when there’s a new episode!
On the Road |
Recorded on the conference floor, "On the Road" includes highlights and interviews from popular legal events.